These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18812375)

  • 1. Outcome in infants exposed to methadone in utero.
    McGlone L; Mactier H; MacKinnon JR
    BMJ; 2008 Sep; 337():a1774. PubMed ID: 18812375
    [No Abstract]   [Full Text] [Related]  

  • 2. [Substitution treatment of drug addicts during pregnancy: consequences for the children?].
    Sandtorv L; Reigstad H; Bruarøy S; Elgen I; Laegreid LM
    Tidsskr Nor Laegeforen; 2009 Feb; 129(4):287-90. PubMed ID: 19219093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy.
    Hamilton R; McGlone L; MacKinnon JR; Russell HC; Bradnam MS; Mactier H
    Br J Ophthalmol; 2010 Jun; 94(6):696-700. PubMed ID: 20410537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual evoked potentials in infants exposed to methadone in utero.
    McGlone L; Mactier H; Hamilton R; Bradnam MS; Boulton R; Borland W; Hepburn M; McCulloch DL
    Arch Dis Child; 2008 Sep; 93(9):784-6. PubMed ID: 18305073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants.
    Miles J; Sugumar K; Macrory F; Sims DG; D'Souza SW
    Child Care Health Dev; 2007 Mar; 33(2):206-12. PubMed ID: 17291325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine.
    Sarfi M; Martinsen H; Bakstad B; Røislien J; Waal H
    Early Hum Dev; 2009 Dec; 85(12):773-8. PubMed ID: 19931991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials.
    Whitham JN; Spurrier NJ; Sawyer MG; Baghurst PA; Taplin JE; White JM; Gordon AL
    Neurotoxicol Teratol; 2010; 32(2):280-8. PubMed ID: 19751825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
    Dryden C; Young D; Hepburn M; Mactier H
    BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
    Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal narcotic exposure: perinatal and developmental effects.
    Kaltenbach KA; Finnegan LP
    Neurotoxicology; 1989; 10(3):597-604. PubMed ID: 2696902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal nonnarcotic substance abuse during pregnancy: effects on infant development.
    Chasnoff IJ; Schnoll SH; Burns WJ; Burns K
    Neurobehav Toxicol Teratol; 1984; 6(4):277-80. PubMed ID: 6514088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In utero drug and alcohol exposure in infants born to mothers prescribed maintenance methadone.
    McGlone L; Mactier H; Hassan H; Cooper G
    Arch Dis Child Fetal Neonatal Ed; 2013 Nov; 98(6):F542-4. PubMed ID: 23836138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual outcome in infants born to drug-misusing mothers prescribed methadone in pregnancy.
    McGlone L; Hamilton R; McCulloch DL; MacKinnon JR; Bradnam M; Mactier H
    Br J Ophthalmol; 2014 Feb; 98(2):238-45. PubMed ID: 24246372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of in utero drug exposure on children's development. Review and recommendations.
    Brooks-Gunn J; McCarton C; Hawley T
    Arch Pediatr Adolesc Med; 1994 Jan; 148(1):33-9. PubMed ID: 7511467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal methadone may cause arrhythmias in neonates.
    Hussain T; Ewer AK
    Acta Paediatr; 2007 May; 96(5):768-9. PubMed ID: 17376175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of heroin misuse in pregnancy: time for a rethink?
    Mactier H
    Arch Dis Child Fetal Neonatal Ed; 2011 Nov; 96(6):F457-60. PubMed ID: 20584799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of the effects of abuse and drugs on pregnancy and offspring.
    Zuckerman B; Frank D; Brown E
    NIDA Res Monogr; 1995; 149():16-38. PubMed ID: 8775833
    [No Abstract]   [Full Text] [Related]  

  • 19. Methadone during pregnancy: the search for a valid animal model.
    Hutchings DE; Zmitrovich A; Church S; Malowany D
    Ann Ist Super Sanita; 1993; 29(3):439-44. PubMed ID: 8172463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy outcome and neurodevelopment of children exposed in utero to psychoactive drugs: the Motherisk experience.
    Loebstein R; Koren G
    J Psychiatry Neurosci; 1997 May; 22(3):192-6. PubMed ID: 9183118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.